Advertisement
Singapore markets closed

  • Straits Times Index

    3,272.72
    +47.55 (+1.47%)
     

  • S&P 500

    5,046.82
    +36.22 (+0.72%)
     

  • Dow

    38,408.62
    +168.64 (+0.44%)
     

  • Nasdaq

    15,597.85
    +146.54 (+0.95%)
     

  • Bitcoin USD

    66,516.74
    +338.87 (+0.51%)
     

  • CMC Crypto 200

    1,427.87
    +13.11 (+0.93%)
     

  • FTSE 100

    8,034.95
    +11.08 (+0.14%)
     

  • Gold

    2,336.70
    -9.70 (-0.41%)
     

  • Crude Oil

    81.61
    -0.29 (-0.35%)
     

  • 10-Yr Bond

    4.6440
    +0.0210 (+0.45%)
     

  • Nikkei

    37,552.16
    +113.55 (+0.30%)
     

  • Hang Seng

    16,828.93
    +317.24 (+1.92%)
     

  • FTSE Bursa Malaysia

    1,561.64
    +2.05 (+0.13%)
     

  • Jakarta Composite Index

    7,110.81
    +36.99 (+0.52%)
     

  • PSE Index

    6,506.80
    +62.72 (+0.97%)
     

Recording of the Fourth Quarter 2020 Investor Conference Webinar

Olainfarm
·1-min read

On March 2, 2021 JSC Olainfarm organized its Investor Conference Online Webinar. During the webinar Chairperson of Management Board Jeroen Weites and member of the management board Zane Kotāne analyzed the financial results of fourth quarter and 12 months 2020 and informed about other recent activities within the company.

The recorded webinar is available online: https://bit.ly/3kBxkw4; and the presentation, demonstrated during the webinar, is available in the attachment. Methodology for alternative performance indicators is disclosed in Annual report for 2020 (page 15).

Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!

JSC Olainfarm, a part of Olainfarm Group, is one of the leading pharmaceutical companies in the Baltic States offering high quality medicine and chemical pharmaceutical products. The business strategy “FORWARD” highlights the company’s main vision – to become one of the TOP10 Central and Eastern European manufacturing companies by 2025.

ADVERTISEMENT

With nearly 50 years of expertise, Olainfarm Group delivers sustainable healthcare products and services with added value to patients in more than 50 countries all over the world via its key subsidiaries – pharmaceutical company JSC Olainfarm, food supplement & medical device producer Silvanols, elastic & compression material producer Tonus Elast, pharmacy chain Latvijas Aptieka and healthcare & diagnostics centres DiaMed & OlainMed.

Additional information:
Jānis Dubrovskis
Investor Relations Advisor of JSC Olainfarm
Phone: +371 29178878
Email: janis.dubrovskis@olainfarm.com

Attachment